Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates

Subepithelial infiltrates secondary to adenoviral keratoconjunctivitis may persist for years and cause blurred vision, halos, glare, and photophobia. These infiltrates arise from immune reaction against the virus, and few studies have reported topical cyclosporine A to be effective in the treatment...

Full description

Bibliographic Details
Main Authors: Betül N. Bayraktutar, Ömür Ö. Uçakhan
Format: Article
Language:English
Published: Karger Publishers 2016-03-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/444784
_version_ 1811268627839582208
author Betül N. Bayraktutar
Ömür Ö. Uçakhan
author_facet Betül N. Bayraktutar
Ömür Ö. Uçakhan
author_sort Betül N. Bayraktutar
collection DOAJ
description Subepithelial infiltrates secondary to adenoviral keratoconjunctivitis may persist for years and cause blurred vision, halos, glare, and photophobia. These infiltrates arise from immune reaction against the virus, and few studies have reported topical cyclosporine A to be effective in the treatment of subepithelial infiltrates. Herein, we describe a patient with adenoviral keratoconjunctivitis-related subepithelial infiltrates who did not respond to treatment with a new topical cyclosporine A emulsion prepared with castor oil (Depores 0.05%; Deva İlaç, Kocaeli, Turkey), while the FDA-approved nanoemulsion formulation provided improvement in symptoms and reduced the inflammatory reaction (Restasis 0.05%; Allergan, Irvine, Calif., USA).
first_indexed 2024-04-12T21:26:18Z
format Article
id doaj.art-e50aaa70f9584ca5a392b4e51e186903
institution Directory Open Access Journal
issn 1663-2699
language English
last_indexed 2024-04-12T21:26:18Z
publishDate 2016-03-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj.art-e50aaa70f9584ca5a392b4e51e1869032022-12-22T03:16:10ZengKarger PublishersCase Reports in Ophthalmology1663-26992016-03-017113514010.1159/000444784444784Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial InfiltratesBetül N. BayraktutarÖmür Ö. UçakhanSubepithelial infiltrates secondary to adenoviral keratoconjunctivitis may persist for years and cause blurred vision, halos, glare, and photophobia. These infiltrates arise from immune reaction against the virus, and few studies have reported topical cyclosporine A to be effective in the treatment of subepithelial infiltrates. Herein, we describe a patient with adenoviral keratoconjunctivitis-related subepithelial infiltrates who did not respond to treatment with a new topical cyclosporine A emulsion prepared with castor oil (Depores 0.05%; Deva İlaç, Kocaeli, Turkey), while the FDA-approved nanoemulsion formulation provided improvement in symptoms and reduced the inflammatory reaction (Restasis 0.05%; Allergan, Irvine, Calif., USA).http://www.karger.com/Article/FullText/444784Adenoviral keratoconjunctivitisSubepithelial infiltratesCyclosporine A
spellingShingle Betül N. Bayraktutar
Ömür Ö. Uçakhan
Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
Case Reports in Ophthalmology
Adenoviral keratoconjunctivitis
Subepithelial infiltrates
Cyclosporine A
title Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
title_full Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
title_fullStr Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
title_full_unstemmed Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
title_short Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
title_sort comparison of efficacy of two different topical 0 05 cyclosporine a formulations in the treatment of adenoviral keratoconjunctivitis related subepithelial infiltrates
topic Adenoviral keratoconjunctivitis
Subepithelial infiltrates
Cyclosporine A
url http://www.karger.com/Article/FullText/444784
work_keys_str_mv AT betulnbayraktutar comparisonofefficacyoftwodifferenttopical005cyclosporineaformulationsinthetreatmentofadenoviralkeratoconjunctivitisrelatedsubepithelialinfiltrates
AT omuroucakhan comparisonofefficacyoftwodifferenttopical005cyclosporineaformulationsinthetreatmentofadenoviralkeratoconjunctivitisrelatedsubepithelialinfiltrates